Mucus of the human olfactory epithelium contains the insulin-like growth factor-I system which is altered in some neurodegenerative diseases

Brain Research

Volumn 835, Issue 2, 1999, Pages 306-314

  Federico, Giovanni ^a   Maremmani, Carlo ^b   Cinquanta, Luisa ^a   Baroncelli, Giampiero Igli ^a   Fattori, Bruno ^c   Saggese, Giuseppe ^a  

^a Endocrine Unit   (Italy)

^b Carrara City Hospital   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Human olfactory epithelium; Idiopathic late onset cerebellar ataxia; Insulin like growth factor binding protein; Insulin like growth factor I; Parkinson's disease

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBELLAR ATAXIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; OLFACTORY EPITHELIUM; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CEREBELLAR ATAXIA; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MUCUS; NEURODEGENERATIVE DISEASES; OLFACTORY MUCOSA; PARKINSON DISEASE; PRECIPITIN TESTS;

EID: 0033600512     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01614-5     Document Type: Article

References (63)

1. Amoore J.E., Venstrom D., Davis A.R. Measurement of specific anosmia. Percept. Motor Skills. 26:1968;143-164.
2. Averbukh E., Weiss O., Halpert M., Yanko R., Moshe R., Nephesh I., Flyvbjerg A., Yanko L., Raz I. Gene expression of insulin-like growth factor-I, its receptor and binding proteins in retina under hypoxic conditions. Metabolism. 47:1998;1331-1336.
3. Awerbuch G.I., Sandyk R. Autonomic function in the early stages of Parkinson's disease. Int. J. Neurosci. 64:1992;7-14.
4. Binoux M., Hossenlopp P., Lassarre C., Hardouin N. Production of insulin-like growth factor and their carrier by rat pituitary gland and brain explants in culture. FEBS Lett. 124:1981;178-184.
5. M. Binoux, C. Lalou, C. Lasarre, B. Segovia, Regulation of IGF bioavailability by IGFBP proteases, in: R.C. Baxter, P.D. Gluckman, R.G. Rosenfeld (Eds.), The Insulin-like Growth Factors and Their Regulatory Proteins, Excerpta Medica, Amsterdam, 1994, pp. 217-226.
6. Bondy C., Werner H., Roberts C.T. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience. 46:1992;909-923.
7. Bonuccelli U., Maremmani C., Del Dotto P., Nocita G., Rossi G., Muratorio A. Olfactory deficits in Parkinson's disease. Neurology. 42(3):1992;440. Suppl.
8. Braunstein G.D., Reviczky A.L. Serum insulin-like growth factor I levels in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 50:1987;792-794.
9. Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Sci. 124:1994;96-107. Suppl.
10. B.R. Brooks, The Norris ALS score: insight into the natural history of amyotrophic lateral sclerosis provided by Forbes Norris, in: F.C. Rose (Ed.), ALS - From Charcot to the Present and into the Future - The Forbes H. Norris (1928-1993) Memorial Volume, Smith-Gordon, London, 1994, pp. 21-29.
11. Calof A.L., Hagiwara N., Holcomb J.D., Mumm J.S., Shou J. Neurogenesis and cell death in olfactory epithelium. J. Neurobiol. 30:1996;67-81.
12. Campanella G., Filla A., De Falco F., Mansi D., Durivage A., Barbeau A. Friedreich's ataxia in the South of Italy. A clinical and biochemical survey of 23 patients. Can. J. Neurol. Sci. 7:1980;351-357.
13. Carson M.J., Behringer R.R., Brinster R., McMorris F.A. Insulin-like growth factor-I increases brain growth and central nervous system myelination in transgenic mice. Neuron. 10:1993;729-740.
14. Crino P.B., Martin J.A., Hill W.D., Greenberg B., Lee V.M.-Y., Trojanowsky J.Q. β-amyloid peptide and amyloid precursors proteins in olfactory mucosa of patients with Alzheimer's disease, Parkinson's disease, and Down syndrome. Ann. Otol. Rhinol. Laryngol. 104:1995;655-661.
15. D'Ercole A.J., Dai Z., Xing Y. Brain growth retardation due to the expression of human insulin-like growth factor binding protein-1 in transgenic mice; an in vivo model for the analysis of IGF function in the brain. Dev. Brain Res. 82:1994;222-231.
16. D'Ercole A.J., Stiles A.D., Underwood L.E. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl. Acad. Sci. U.S.A. 81:1984;935-939.
17. Daniel S.E., Hawkes C.H. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet. 340:1992;186.
18. Doty R.L., Stern M.B., Pfeiffer C., Gollomp S.M., Hurtig H.I. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 55:1992;138-142.
19. Elian M. Olfactory impairment in motor neuron disease: a pilot study. J. Neurol. Neurosurg. Psychiatry. 54:1991;927-928.
20. Farbman A.I., Buchholz A. Transforming growth factor-α and other growth factors stimulate cell division in olfactory epithelium in vitro. J. Neurobiol. 30:1996;267-280.
21. S. Fahan, R.L. Elton, Y. Agid, A. Barbeau, D.B. Calne, R.C. Duvoisin, M.M. Hohen, J. Jankovic, H.L. Klawans, A.E. Lang, X. Lataste, A.N. Lieberman, C.D. Marsden, C.H. Markham, R. Mayeux, U.K. Rinne, G.M. Stern, P. Teychenne, M.D. Yahr, Unified Parkinson's disease rating scale, in: S. Fahn, C.D. Marsden, D. Calne, M. Goldstein (Eds.), Recent Developments in Parkinson's Disease, Vol. 2, MacMillian Healthcare, Florham Park, 1987, pp. 153-164.
22. Gargosky S.E., Pham H., Wilson K.F., Liu F., Giudice L.C., Rosenfeld R.G. Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: discrepancies between radioimmunoassay and ligand blotting. Endocrinology. 131:1992;3051-3060.
23. M.L. Getchell, T.K. Mellert, Olfactory mucus secretion, in: T.V. Getchell, R.L. Doty, L.M. Bartoshukm, J.B. Snow Jr. (Eds.), Smell and Taste in Health and Disease, Raven Press, New York, 1991, pp. 83-95.
24. Getchell T.V., Margolis F.L., Getchell M.L. Perireceptor and receptor events in vertebrate olfaction. Prog. Neurobiol. 23:1984;317-345.
25. Giudice L.C., Farrell E.M., Pham H., Rosenfeld R.G. Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) and IGFBP-2 in human follicular fluid. J. Clin. Endocrinol. Metab. 71:1990;1330-1338.
26. Gluckman P., Klempt N., Guan J. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem. Biophys. Res. Commun. 31:1992;593-599.
27. Goodyer C.G., De Stephano L., Lai W.H., Guyda H.G., Posner B.I. Characterization of insulin-like growth factor receptors in rat anterior pituitary, hypothalamus, and brain. Endocrinology. 114:1984;1187-1195.
28. Han W.K.M., Lauder J.M., D'Ercole A.J. Characterization of somatomedin/insulin-like growth factor receptors and correlation with biologic action in culture neonatal rat astroglial cells. J. Neurosci. 7:1987;501-511.
29. A.E. Harding, Idiopathic late onset cerebellar ataxia, in: A.E. Harding (Ed.), The Hereditary Ataxias and Related Disorders, Churchill Livingstone, Edinburgh, 1984, pp. 166-173.
30. Haselbacher G.K., Schwab M.E., Pasi A., Humbel R.E. Insulin-like growth factor-II (IGF-II) in human brain: regional distribution of IGF-II and of higher molecular mass forms. Proc. Natl. Acad. Sci. U.S.A. 82:1985;2153-2157.
31. Hatt H. Molecular mechanisms of olfactory processing in the mammalian olfactory epithelium. ORL. 58:1996;183-194.
32. Holly M.P., Claffey D.C.P., Cwyfan-Hughes S.C., Frost V.J., Yateman M.E. Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regulation. 3:1993;88-91.
33. Hossenlopp P., Seurin D., Segovia-Quinson B., Binoux M. Identification of an insulin-like growth factor-binding protein in human cerebrospinal fluid with a selective affinity for IGF-II. FEBS Lett. 208:1986;439-444.
34. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154:1986;138-143.
35. Jones J.I., Clemmons D.R. Insulin-like factors and their binding proteins: biological actions. Endocr. Rev. 16:1995;3-34.
36. Kiefer M.C., Schimd C., Waldvogel M. Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization. Growth Regulation. 3:1993;56-59.
37. Larsen J.P., Dupont E., Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol. Scand. 89:1994;242-251.
38. Maremmani C., Bonuccelli U., Nocita G., Del Dotto P., Nuti A., Muratorio A. Olfactory deficits in neurodegenerative disorders. Ital. J. Neurol. Sci. 12:1991;78-83.
39. Maremmani C., Fattori B., De Ciccio M., Ceravolo R., Ghilardi P.L., Muratorio A. Electrophoretic pattern of physiological human nasal secretions. Rhinology. 34:1996;147-150.
40. C. Maremmani, G. Nocita, A. Nuti, R. Ceravolo, U. Bonuccelli, Olfactory deficits in late onset cerebellar ataxia, Société Française de Neurologie, Journées Internaptionales Paris, France, 1992, p. 32.
41. Masur H., Schulte-Oversohl U., Papke K., Oberwittler C., Vollmer J. Sympathetic skin response in patients with amyotrophic lateral sclerosis. J. Funct. Neurol. 10:1995;131-135.
42. Murata Y., Harada T., Ishizaki F., Izumi Y., Nakamura S. Autonomic dysfunction in Parkinson's disease and vascular parkinsonism. Acta Neurol. Scand. 96:1997;359-365.
43. Ota A., Wilson G.L., Spilberg O., Pruss R., LeRoith D. Functional insulin-like growth factor-I receptors are expressed by neural-derived continuous cell line. Endocrinology. 122:1988;145-152.
44. Pelosi P., Maida R. Odorant-binding proteins in vertebrates and insects: similarities and possible common function. Chem. Sens. 15:1990;205-215.
45. Pons S., Torres-Aleman I. Basic fibroblast growth factor modulates insulin-like growth factor-I, its receptor, and its binding proteins in hypothalamic cell cultures. Endocrinology. 131:1992;2271-2278.
46. Rechler M.M., Brown A.L. Insulin-like growth factor binding proteins: gene structure and expression. Growth Regulation. 12:1992;55-68.
47. Richardson R.L., Hausman G.J., Wright J.T. Growth factor regulation of insulin-like growth factor (IGF) binding proteins (IGFBP) and preadipocyte differentiation in porcine stromal-vascular cell cultures. Growth Dev. Aging. 62:1998;3-12.
48. Rosenfeld R.G., Pham H., Oh Y., Lamson G., Giudice L. Identification of insulin-like growth factor-binding protein-2 (IGFBP-2) and a low molecular weight IGFBP in human seminal plasma. J. Clin. Endocrinol. Metab. 70:1990;551-553.
49. Russo V.C., Edmonson S.R., Mercuri F.A., Buchanan C.R., Werther G.A. Identification, localization, and regulation of insulin-like growth factor binding proteins and their messenger ribonucleic acids in the newborn rat olfactory bulb. Endocrinology. 135:1994;1437-1446.
50. Sandroni P., Ahlskog J.E., Fealey R.D., Low P.A. Autonomic involvement in extrapyramidal and cerebellar disorders. Clin. Auton. Res. 1:1991;147-155.
51. Sara V.R., Carlsson-Skwirut C., Andersson C. Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor-I. Proc. Natl. Acad. Sci. U.S.A. 83:1986;4904-4907.
52. Sara V.R., Hall K., von Holtz H., Humbell R., Sjogren B., Wetterberg L. Evidence for the presence of specific receptors for insulin-like growth factor-1 (IGF-I) and 2 (IGF-II) and insulin throughout the adult human brain. Neurosci. Lett. 34:1982;39-44.
53. Sara V.R. Insulin-like growth factors and their binding proteins. Physiol. Rev. 70:1990;591-614.
54. Shemer J., Raizada M.K., Masters B.A., Ota A., LeRoith D. Insulin-like growh factor-I receptors in neuronal and glial cells. J. Biol. Chem. 262:1987;7693-7699.
55. Shimasasaki S., Shimonaka M., Zhang H., Ling N. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J. Biol. Chem. 266:1991;10646-10653.
56. Smith R.A., Melmed S., Sherman B. Recombinant growth hormone treatment of amyotrophic lateral sclerosis. Muscle Nerve. 16:1993;624-633.
57. Thissen J.P., Ketelslegers J.M., Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 15:1994;80-101.
58. Torres-Aleman I., Naftolin F., Robbins R. Trophic effects of insulin-like growth factor I on fetal rat hypothalamic cells in culture. Neuroscience. 35:1990;601-608.
59. Torres-Aleman I., Pons S., Santos-Benito F.F. Survival of Purkinje cells in cerebellar cultures is increased by insulin-like growth factor I. Eur. J. Neurosci. 4:1992;864-869.
60. Torres-Aleman I., Pons S., Arevalo M.A. The insulin-like growth factor I system in the cerebellum: developmental regulation and effect on neuronal survival and differentiation. J. Neurosci. Res. 38:1994;117-126.
61. I. Torres-Aleman, V. Barrios, A. Lledo, J. Berciano, The insulin-like growth factor I system in cerebellar degeneration, Ann. Neurol. (1996) 335-342.
62. I. Torres-Aleman, V. Barrios, J. Berciano, The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis, Neurology (1998) 772-776.
63. Yokota T., Hayashi M., Tanabe H., Tsukagoshi H. Sympathetic skin response in patients with cerebellar degeneration. Arch. Neurol. 50:1993;422-427.